<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02050646</url>
  </required_header>
  <id_info>
    <org_study_id>1303011696</org_study_id>
    <secondary_id>YSOM Pediatrics Department</secondary_id>
    <nct_id>NCT02050646</nct_id>
  </id_info>
  <brief_title>The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis</brief_title>
  <official_title>The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a salt restriction diet improves immune&#xD;
      parameters in patients with autoimmune hepatitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The etiology of autoimmune hepatitis (AIH) is unknown although both genetic and environmental&#xD;
      factors are thought to be involved. A defect in immune regulation affecting regulatory T&#xD;
      cells (Tregs) has been demonstrated in AIH. Tregs function in the maintenance of immune&#xD;
      homeostasis by controlling autoreactive immune responses to self-antigens.&#xD;
&#xD;
      Rationale: the western diet has been postulated as a potential environmental risk factor for&#xD;
      the increasing incidence of autoimmune diseases in developed countries. Data from the&#xD;
      investigators' laboratory also suggests that increased dietary salt intake might represent an&#xD;
      environmental risk factor for the development of autoimmune diseases through the induction of&#xD;
      pathogenic Th17 cells. The dramatic in vitro effects of high salt on the induction of&#xD;
      pathogenic Th17 cells from na√Øve human CD4 cells {Kleinewietfeld, Hafler. Nature. 2013 Apr&#xD;
      25;496(7446):518-22. doi: 10.1038/nature11868.}, and block of in vitro Treg suppression, in&#xD;
      line with in vivo effects on worsening murine experimental autoimmune encephalomyelitis&#xD;
      (EAE), have prompted the investigators to examine the effects of increased dietary sodium&#xD;
      chloride in a human in vivo system.&#xD;
&#xD;
      The investigators hypothesize that excess dietary salt may function as an environmental&#xD;
      trigger that favors induction and expansion of pathogenic Th17 cells and leads to functional&#xD;
      impairment of Tregs, thereby favoring development of autoimmunity. The investigators aim to&#xD;
      study their established in vitro model in humans by altering the salt intake in patients over&#xD;
      a 20-day period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 27, 2013</start_date>
  <completion_date type="Actual">June 2021</completion_date>
  <primary_completion_date type="Actual">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in production of pathogenic TH17 cells.</measure>
    <time_frame>26 days</time_frame>
    <description>Measuring TH17 cells by flow cytometry and qRT-PCR. There are no known normal ranges. The investigator will calculate the change by observing the difference from baseline values.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in regulatory T cell function.</measure>
    <time_frame>26 days</time_frame>
    <description>Measuring T cell function by flow cytometry. There are no known normal ranges. The investigator will calculate the change by observing the difference from baseline values.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Autoimmune Hepatitis</condition>
  <arm_group>
    <arm_group_label>Low salt/ Liberal salt Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cross-over trial of liberal salt and low salt diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liberal salt/Low salt diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cross-over trial of low salt and liberal salt diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Salt Diet</intervention_name>
    <description>On Day 0, patients will be randomized to one of the two crossover liberal/low or low/liberal salt diet groups. Each subject will complete two controlled dietary phases: 10-days of low salt diet, a washout period of 3-days, and 10-days of liberal salt diet.</description>
    <arm_group_label>Liberal salt/Low salt diet</arm_group_label>
    <arm_group_label>Low salt/ Liberal salt Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liberal salt diet</intervention_name>
    <description>On Day 0, patients will be randomized to one of the two crossover liberal/low or low/liberal salt diet groups. Each subject will complete two controlled dietary phases: 10-days of low salt diet, a washout period of 3-days, and 10-days of liberal salt diet.</description>
    <arm_group_label>Liberal salt/Low salt diet</arm_group_label>
    <arm_group_label>Low salt/ Liberal salt Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults 18-50 years of age&#xD;
&#xD;
          -  Children 1-17 years of age&#xD;
&#xD;
          -  ALT and/or ALP/GGT level &gt; 2X upper limit of normal&#xD;
&#xD;
          -  ANA or SMA &gt;/= 1:40&#xD;
&#xD;
          -  ANA or SMA &gt;/= 1:80&#xD;
&#xD;
          -  or LKM &gt;/= 1:40&#xD;
&#xD;
          -  or SLA positive&#xD;
&#xD;
          -  IgG &gt; upper limit of normal&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic hepatitis C&#xD;
&#xD;
          -  Decompensated Liver Disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Udeme Ekong, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>November 4, 2013</study_first_submitted>
  <study_first_submitted_qc>January 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2014</study_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autoimmune hepatitis</keyword>
  <keyword>Liver dysfunction</keyword>
  <keyword>Elevated serum auto antibodies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis, Autoimmune</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

